Inventor
KISFALUDY LAJOS
HU27 patents
⚠️ This page may combine multiple inventors who share the name “KISFALUDY LAJOS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RICHTER GEDEON VEGYESZET
26 patentsUS4388304AJun 14, 1983
Angiotensin-II analogues with antagonizing effects, containing an ester group in position 8, and a process for the preparation thereof
RICHTER GEDEON VEGYESZET66 citations95
US4428938AJan 31, 1984
Peptides affecting the immune regulation and a process for their preparation
RICHTER GEDEON VEGYESZET66 citations93
US4330532AMay 18, 1982
Angiotensin-II analogues with antagonizing effects, containing an α-hydroxycarboxylic acid residue in position 8, and a process for the preparation thereof
RICHTER GEDEON VEGYESZET18 citations81
US4035370AJul 12, 1977
Alkaloid esters
RICHTER GEDEON VEGYESZET23 citations81
US5041535AAug 20, 1991
Antileukemic and immunostimulant peptides
RICHTER GEDEON VEGYESZET6 citations72
US4299821ANov 10, 1981
Tripeptides acting on the central nervous system and a process for the preparation thereof
RICHTER GEDEON VEGYESZET7 citations72
US5008246AApr 16, 1991
Novel peptides suppressing the function of the immune system, pharmaceutical compositions containing them and process for preparing same
RICHTER GEDEON VEGYESZET11 citations71
US4179433ADec 18, 1979
Angiotensin II antagonist peptides containing an alpha-aminooxyacid in the position-1
RICHTER GEDEON VEGYESZET7 citations70
US4045433AAug 30, 1977
1,3,4,5-Tetrahydro-2H-1,4-benzodiazepin-2-ones
RICHTER GEDEON VEGYESZET8 citations70
US4209442AJun 24, 1980
Angiotensin II analogs and process for the preparation thereof
RICHTER GEDEON VEGYESZET7 citations68
US3953415AApr 27, 1976
Process for the preparation of biologically active polypeptides containing aspartyl group
RICHTER GEDEON VEGYESZET8 citations67
US4384991AMay 24, 1983
Process for the preparation of a biologically active substance for selective inhibition of the proliferation of leukemic and normal myeloid cells
RICHTER GEDEON VEGYESZET12 citations65
US4530964AJul 23, 1985
Pharmaceutically active copolymers, process for their preparation and pharmaceutical compositions containing them
RICHTER GEDEON VEGYESZET4 citations58
US4183909AJan 15, 1980
Phenylglycine-containing new peptides with gastrine effects and a process for the preparation thereof
RICHTER GEDEON VEGYESZET3 citations58
US4172130AOct 23, 1979
α-AMINOACYL CONTAINING NEW PEPTIDES WITH GASTRIN EFFECTS AND A PROCESS FOR THE PREPARATION THEREOF
RICHTER GEDEON VEGYESZET4 citations58
US4021421AMay 3, 1977
Benzodiazepine derivatives
RICHTER GEDEON VEGYESZET2 citations58
US5312812AMay 17, 1994
Pharmaceutical compositions comprising novel oligopeptides exhibiting selective inhibiting effect upon the proliferation of hemopoietic cells
RICHTER GEDEON VEGYESZET3 citations57
US4329341AMay 11, 1982
5-Phenyl-1,3,4,5-tetrahydro-2H-1,4-benzodiazepin-2-ones, and pharmaceutical compositions containing them
RICHTER GEDEON VEGYESZET3 citations57
US4672054AJun 9, 1987
Process for the preparation of angiotensin-II analogues substituted in the 1-, 5- and 8- positions
RICHTER GEDEON VEGYESZET2 citations56
US4406835ASep 27, 1983
Tranquillo-sedative benzodiazepine derivatives
RICHTER GEDEON VEGYESZET0 citations49
US4342755AAug 3, 1982
Tranquillo-sedative benzodiazepine derivatives
RICHTER GEDEON VEGYESZET0 citations49
US5093320AMar 3, 1992
Novel peptides inhibiting the maturation of t-lymphocytes and the activity of macrophages, pharmaceutical compositions containing them and process for preparing same
RICHTER GEDEON VEGYESZET1 citations48
US5252558AOct 12, 1993
Pentapeptide having specific inhibiting effect on epidermal cell proliferation, the salts thereof, pharmaceutical compositions comprising the same and a process for the preparation of the pentapeptide and the pharmaceutical compositions
RICHTER GEDEON VEGYESZET0 citations44
US4260595AApr 7, 1981
Pharmaceutical compositions and process for the preparation of same
RICHTER GEDEON VEGYESZET0 citations44
US4755510AJul 5, 1988
Novel anticonvulsive tetrahydro-1,2,4-oxadiazine-5-thion derivatives and use
RICHTER GEDEON VEGYESZET0 citations42
US4371534AFeb 1, 1983
N4-Substituted tetrahydro-1,2,4-oxadiazin-5-one derivatives having anticonvulsive activity and pharmaceutical compositions containing them
RICHTER GEDEON VEGYESZET1 citations42